Managing ICU Arrhythmias: Rapid Rate Control Strategies Using β1-Selective Agents

Join this free SCCM webcast for dynamic, case-driven discussions that dive into the complexities of managing new-onset atrial fibrillation in critically ill patients. Discover how a highly selective beta-blocker, known for its rapid onset and short half-life, can be a game changer in achieving swift and stable rate control. Expert faculty will unpack the pharmacologic nuances of beta-antagonists in the ICU setting and deliver actionable insights to help you optimize hemodynamic stability when it matters most.

Thursday, November 13, 2025
11:00 a.m. – 12:00 p.m. Central Time

Reserve Your Free Spot

Please log in or create an account before clicking Register Now.
To log in or create an account, click here or navigate to the menu bar at the top of the page and select Log In then Sign In/Sign Up.

Can't make the live event? Register anyway and receive a link to the recording.

This webcast is supported by AOP Health.

Learning Objectives

• Apply evidence-based strategies in case-based scenarios for rate control in critically ill patients with new-onset atrial fibrillation using landiolol to support safe and effective ICU management
• Explain the pharmacologic characteristics and mechanism of action of landiolol for the short-term reduction of ventricular rate in adult patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter